• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Search Results for: patent

TRIPS In Question During Social Forum Discussion On Access To Medicines

23/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment

Intellectual property rights are hindering access to medicines by maintaining monopolies and high prices, according to speakers at an annual United Nations forum on human rights last week. Flexibilities enshrined in the World Trade Organization intellectual property agreement are hampered by political and economical pressure, they said, and a new system should be devised for pharmaceutical products.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WHO, WTO/TRIPS

Neuchâtel Event Looks At Swiss Innovation, Competitiveness

20/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment

NEUCHATEL – Switzerland is among the best students of global innovation. It continues to score at the top of global indexes and reports on innovation and competitiveness. At a seminar last week at the University of Neuchâtel, speakers gave their views on that success.

Filed Under: IP Policies, Subscribers, Themes, Venues, Copyright Policy, English, Europe, Finance, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer

UK Defence Science And Tech Lab To Offer IP Royalty-Free Licences

11/02/2015 by William New, Intellectual Property Watch Leave a Comment

The Defence Science and Technology Laboratory (Dstl) has announced it will participate in a plan for sharing some of its intellectual property for research royalty-free, making it the first United Kingdom government agency to do so.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Europe, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer

United States, Japan To Join International Design System At WIPO

11/02/2015 by Elena Bourtchouladze for Intellectual Property Watch 1 Comment

On 13 February, the United States and Japan will deposit their instruments of accession to the Geneva Act of July 2, 1999 (the Geneva Act) of the WIPO’s Hague Agreement Concerning the International Registration of Industrial Designs (the Hague Agreement). A ceremony will be held at the World Intellectual Property Organization, which manages the agreement.

Filed Under: IP Policies, Language, Themes, Venues, English, Innovation/ R&D, Patents/Designs/Trade Secrets, WIPO

Year Ahead: Key IP-Related Issues, Dates At The WTO In 2015

09/02/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment

This year is shaping up to be a busy one for the World Trade Organization, and intellectual property issues are among those coming up.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, Development, Enforcement, English, Health & IP, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer

06/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment

The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Health & IP, Human Rights, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy

South Africa Supreme Court Of Appeal Losing Its Shape

05/02/2015 by Intellectual Property Watch Leave a Comment

South Africa’s Supreme Court of Appeal has been blessed for the past few decades by having in its ranks judges who have experience and expertise in the field of Intellectual Property Law, writes law professor Owen Dean. With the recent retirement of Louis Harms, the bench at the Supreme Court of Appeal has been denuded of judges who can be regarded as IP experts. The paucity of IP experience on the bench is regrettably beginning to show.

In recent times the Supreme Court of Appeal has given three IP judgments in trade mark cases which, it is respectfully submitted, have been wrongly decided and are not in harmony with the principles of trade mark law and practice, Dean argues.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Africa, Enforcement, English, IP Law, Regional Policy, Trademarks/Geographical Indications/Domains

Unlimited Potential: The Innovation Renaissance Is Now

05/02/2015 by Intellectual Property Watch, Intellectual Property Watch 2 Comments

By Patrick Kilbride At no other time in history has humanity enjoyed such a boundless period of innovation.  The human experience is literally changing day-to-day as new medicines and new technologies create solutions to seemingly insurmountable global challenges such as poverty, hunger, disease, and climate change.  This 21st century innovation renaissance could not be more […]

Filed Under: Features, Themes, Venues, Enforcement, Finance, Innovation/ R&D, North America, Paid Content, Regional Policy

The Latest News In Intellectual Property From ANEPI Ecuador

02/02/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment

Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Copyright Policy, Development, English, Español, Innovation/ R&D, Latin America/Caribbean, Paid Content, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains

Special Report: Will India Bend To US Pressure On IP Rights?

31/01/2015 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments

It is no secret that the United States has been scaling up pressure on India to adopt intellectual property measures similar to those common in the United States and the European Union. But to what extent does India’s new government led by the business-friendly Narendra Modi see eye to eye with US official position? Can India, the “pharmacy of the world”, resolve the friction between pharmaceutical patents and access to affordable medicines without putting off foreign investors? The vitriolic and polarising debate surrounding these questions has got a fresh lease of life following US President Barack Obama’s landmark three-day visit to India this week.

While Indian and American business moguls are bullish about the future, Indian generic drug-makers as well as health activists within and outside India are deeply anxious about the shape of things to come

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Asia/Pacific, Copyright Policy, Development, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains

  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • …
  • 347
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting